Asia Pacific Prefilled Syringes Market

The Asia Pacific prefilled syringes market is projected to reach USD 3.14 billion by 2030 from USD 1.75 billion in 2025, at a CAGR of 12.4% during the forecast period. Market growth is largely driven by the increasing prevalence of chronic diseases, the rising demand for self-administration, and the advantages of prefilled syringes, such as reduced risk of contamination and dosing errors. However, the presence of alternative drug delivery systems and stringent regulatory requirements limits the market growth of prefilled syringes.

The prominent players in the Asia Pacific prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), and Baxter (US).

To know about the assumptions considered for the study download the pdf brochure

Key players in the Asia Pacific prefilled syringes market have adopted a mix of organic and inorganic growth strategies, including product launches, acquisitions, collaborations, partnerships, agreements, and expansions, to enhance their global presence and increase market share. These initiatives have enabled them to expand geographically and deliver prefilled syringes across diverse regions.

In July 2024, West Pharmaceutical Services, Inc. expanded its presence in South Korea with a new office in Seoul and an upgraded warehouse in Hwaseong. This expansion enhanced West’s ability to support injectable drug packaging and delivery, aligning with the country’s growing biologics sector.

In March 2023, SCHOTT allocated an investment of USD 79 million (approximately INR 660 Crore) over the past three years to expand its pharmaceutical glass production in India in response to rising demand in Asia.

BD:

BD is a leading global medical technology company in the Asia Pacific prefilled syringes market, specializing in innovative medical devices, laboratory equipment, and injectable drug delivery solutions. BD’s products, including advanced prefilled syringes and safety-engineered systems, support improved clinical outcomes, enhance patient safety, and streamline healthcare workflows across hospitals, clinics, and pharmaceutical manufacturing. Becton, Dickinson and Company (BD) offers a broad portfolio spanning syringes, drug delivery systems, diagnostics, and clinical research tools, supporting healthcare across the care continuum. Its operations are organized into three segments—BD Medical, BD Life Sciences, and BD Interventional—with BD Medical focusing on medication delivery, management, and pharmaceutical systems. The company operates in more than 190 countries across North America, Latin America, Europe, the Middle East, Africa, and Asia.

Gerresheimer AG:

Gerresheimer is one of the leaders in medicine packaging, drug delivery devices, and solutions, offering the most extensive product portfolio for pharmaceuticals, healthcare, well-being, and biotechnology in the Asia Pacific prefilled syringes market. The company's diverse array of products and solutions comprises pharmaceutical packaging and items designed for the secure and easy administration of medications. Gerresheimer operates under 3 segments: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company has over 40 manufacturing plants across Europe, North America, South America, and Asia. Some of its notable subsidiaries include Gerresheimer Querétaro S.A. (Mexico), Gerresheimer Glass Inc. (US), Gerresheimer Plásticos São Paulo Ltda. (Brazil), Kimble Chase (US), Gerresheimer Medical Plastic Systems Dongguan Co. Ltd. (China), and Triveni Polymers Pvt. Ltd. (India).

Schott:

Schott Pharma is a leading global supplier of pharmaceutical primary packaging and drug delivery solutions, specializing in glass and polymer containers for injectable drugs, in the Asia Pacific prefilled syringes market. As a subsidiary of SCHOTT, it supports pharmaceutical and biotech companies with high-quality, ready-to-use solutions for sensitive biologics and vaccines. SCHOTT develops, manufactures, and markets specialty glass materials and glass-ceramics. The company offers a broad portfolio of special glass, specialty materials, components, and systems. SCHOTT Group's operations are organized into three different segments, i.e., Precision Materials, Optical Industries, and Home Appliances. The Pharma business unit in the Precision Materials segment offers syringes, vials, ampoules, and cartridges. Geographically, the company operates manufacturing sites and sales offices in 33 countries. Its operations are spread across Europe, Asia, the Middle East and Africa, North America, and South America.

MARKET RANKING

In the Asia Pacific prefilled syringes market, the competitive landscape is shaped by a mix of leading multinational corporations and strong regional players. BD (US) holds a leading position, driven by its broad product portfolio, global distribution network, and trusted brand legacy. The company has sustained its leadership through continuous product innovation and consumer-focused marketing. Gerresheimer AG (Germany) is another major player, particularly in international markets. SCHOTT (Germany) also holds a significant share, offering a variety of products. Other notable companies include West Pharmaceutical Services, Inc. (US) and AptarGroup Inc. (US), which contribute to market diversity through differentiated formulations and expansive retail reach. Collectively, these players dominate the Asia Pacific prefilled syringes landscape, setting industry standards in formulation science, consumer trust, and global reach.

Related Reports:

Asia Pacific Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com